14
Views
10
CrossRef citations to date
0
Altmetric
Research Article

In Vitro Effects of Gallamine on Dissociation Kinetics of (3H) N-Methylscopolamine and (3H) Pirenzepine from Rat Brain Muscarinic Receptors

, &
Pages 47-61 | Published online: 26 Sep 2008
 

Abstract

Gallamine inhibited the binding of both (3H) N-Methylscopolamine ((3H)NMS) and (3H) Pirenzepine ((3H)PZ) in the hippocampus, striatum and cortex of rat brain. Competition curves between gallamine and (3H)PZ suggested that gallamine recognized an homogeneous class of receptors (Hill coefficient close to 1) whereas competition curves, using (3H) NMS as tracer, were compatible with two classes of gallamine receptors (Hill coefficient below 0.7). The latter phenomenon could be explained, at least partially, by the inhibitory effect exerted by gallamine on the koff of (3H)NMS. This effect was already observed at a 10 μM gallamine concentration and reached 100% at 1 mM (a gallamine concentration reducing the koff of (3H) PZ by 30 % only). The nature of the radioligand rather than the relative abundance of M1—M2 receptors was probably responsible for this discrepancy.

Gallamine inhibited the (3H) NMS dissociation rate from brain M1 and M2 receptors (i.e. receptors with high and intermediate affinity for pirenzepine) with a lower potency than from cardiac M2 receptors (i.e. receptors with low affinity for pirenzepine).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.